Yahoo
Taiwan - Delayed Quote TWD

Johnson Health Tech .Co., Ltd. (1736.TW)

123.50 0.00 (0.00%)
At close: October 30 at 1:30:31 PM GMT+8
Chart Range Bar
Loading chart for 1736.TW
  • Previous Close 123.50
  • Open 123.50
  • Bid --
  • Ask --
  • Day's Range 122.00 - 125.50
  • 52 Week Range 102.00 - 168.50
  • Volume 531,419
  • Avg. Volume 579,646
  • Market Cap (intraday) 37.469B
  • Beta (5Y Monthly) 0.15
  • PE Ratio (TTM) 11.18
  • EPS (TTM) 11.05
  • Earnings Date (est.) --
  • Forward Dividend & Yield 4.50 (3.64%)
  • Ex-Dividend Date Aug 4, 2026
  • 1y Target Est 195.00

Johnson Health Tech .Co., Ltd., together with its subsidiaries, manufactures and sells fitness equipment in the Americas, Europe, Asia, and internationally. The company offers cardiopulmonary resuscitation fitness machines, weight training machines, electric massage chairs and related motors, and instruments and electronic control panels, as well as instruments and electrical chairs, and related motors. It is also involved in buying and selling bodybuilding and weight training machines, and hearing aid; research and development, manufacture, and sale of massage chair and sports equipment; provision of video streaming and transmission, and catering services; food wholesale; leasing business; and cultural communication activities. The company sells its products under the MATRIX, Vision Fitness, BowFlex, Schwinn, and Horizon brands. Johnson Health Tech .Co., Ltd. was incorporated in 1975 and is headquartered in Taichung, Taiwan.

www.johnsonhealthtech.com

--

Full Time Employees

December 31

Fiscal Year Ends

Leisure

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is TSEC CAPITALIZATION WEIGHTED ST (^TWII) .

YTD Return

1736.TW
15.28%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
56.10%

1-Year Return

1736.TW
17.20%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
59.83%

3-Year Return

1736.TW
95.05%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
179.95%

5-Year Return

1736.TW
130.84%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
166.15%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 13.27B
Earnings 969.16M
Profit Margin 7.31%

Q2

FY25

Q3

FY25

Q4

FY25

Q2

FY26

0
5B
10B
15B
2.0%
4.0%
6.0%
8.0%

Analyst Insights

View More

Analyst Price Targets

195.00
195.00 Average
123.50 Current
195.00 High

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    5.94%

  • Return on Assets (ttm)

    6.35%

  • Return on Equity (ttm)

    27.91%

  • Revenue (ttm)

    56.47B

  • Net Income Avi to Common (ttm)

    3.35B

  • Diluted EPS (ttm)

    11.05

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    3.39B

  • Total Debt/Equity (mrq)

    123.92%

  • Levered Free Cash Flow (ttm)

    2.53B

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: